Greg Abel Has Kept 60% of Berkshire's $359 Billion Stock Portfolio in Just 5 Companies, Even After Eliminating 16 Other Positions in His First Quarter. Is That Concentration a Risk for Shareholders?

Berkshire Hathaway’s top 5 U.S.-listed equity holdings (Apple, American Express, Alphabet, Bank of America, Coca-Cola) account for ~60% of its portfolio. Since Greg Abel took over in January 2026, Berkshire trimmed its Bank of America stake by 5.9% in Q2 2026 while increasing Alphabet by 45.2% (~$17B), leaving Apple and the other core positions largely unchanged. The article argues concentration downside is limited—for example, a 50% Apple drawdown would reduce Berkshire’s position value by ~$35.25B versus ~$1T market cap and ~$750B shareholders’ equity—while the bigger risk is performance versus Buffett’s long-run track record.

Analysis

The market should not read the portfolio concentration as balance-sheet fragility; it is mostly a function of embedded unrealized gains in legacy winners. The real risk is not that these positions create forced selling, but that the market gradually stops paying for the myth of succession continuity and starts valuing BRK more like a mature capital allocator with a narrower edge. That puts the burden on Abel to prove he can rotate capital without diluting the premium historically attached to Berkshire's judgment.

Second-order, the clearest relative beneficiary is GOOGL: a large, visible endorsement from a long-duration capital allocator can support the multiple at the margin, especially if it attracts more quality-factor ownership. BAC remains the cleanest source of latent overhang; even modest trimming signals that Berkshire views the bank as lower-conviction than other financial exposures, which can cap upside versus XLF and other money-center peers until the next filing cycle. AXP and KO are the stabilizers: if they stay intact, they reinforce BRK's defensive profile; if either is meaningfully cut, the market would likely widen the conglomerate discount.

Contrarian view: consensus is over-focusing on headline concentration and underestimating the optionality created by Berkshire's liquidity. With hundreds of billions in cash and no near-term funding stress, drawdowns in AAPL or other top holdings are more likely to be accounting noise than a catalyst for value destruction. The more relevant watch item over 1-3 months is whether the next 13F shows continued rotation into GOOGL and out of BAC; over 6-18 months, the falsifier is persistent underperformance versus the S&P on the back of weak capital allocation rather than stock selection risk.

Key Decisions for Investors

• No immediate directional trade in BRK.B/BRKA: concentration alone is not a sell signal, and the cash position makes forced-deleveraging risk negligible. Reassess after the next 13F and operating earnings print.
• Relative long GOOGL vs short BAC for 1-3 months if the rotation thesis persists. Entry is best on any post-filing volatility; thesis breaks if BAC rallies on clearer NII inflection or GOOGL loses support on ad/regulatory headlines.
• Treat BRK.B as a quality compounder, not a momentum trade; accumulate only on relative weakness versus SPY/XLF if the discount widens without deterioration in insurance underwriting or float growth. Time horizon: 3-6 months.
• Watch AXP and KO as narrative anchors. If either is materially reduced in future filings, expect BRK's conglomerate discount to widen and consider trimming BRK.B exposure; if they remain stable, the stock should continue to trade on stability rather than concentration angst.